Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Hromas

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Nature Communications|November 26, 2021
Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activityDongwen Lv, Pratik Pal, Xingui Liu, et al.
EMBO Molecular Medicine|February 19, 2025
Targeting cIAP2 in a novel senolytic strategy prevents glioblastoma recurrence after radiotherapyNozomi Tomimatsu, Luis Fernando Macedo Di Cristofaro, Suman Kanji, et al.
Nature Communications|January 26, 2023
DNA binding and RAD51 engagement by the BRCA2 C-terminus orchestrate DNA repair and replication fork preservationYoungho Kwon, Heike Rösner, Weixing Zhao, et al.
Cancer Research|March 5, 2022
Tumor Intrinsic PD-L1 Promotes DNA Repair in Distinct Cancers and Suppresses PARP Inhibitor-Induced Synthetic LethalityAnand V R Kornepati, Jacob T Boyd, Clare E Murray, et al.
Communications Biology|May 24, 2022
Targeting aberrant replication and DNA repair events for treating breast cancersSubapriya Rajamanickam, Jun Hyoung Park, Panneerdoss Subbarayalu, et al.
European Urology Oncology|November 15, 2024
Colibactin Exerts Androgen-dependent and -independent Effects on Prostate CancerRaag Agrawal, Sarah Al-Hiyari, Rupert Hugh-White, et al.
Cell Stem Cell|February 15, 2025
PSPC1 exerts an oncogenic role in AML by regulating a leukemic transcription program in cooperation with PU.1Juyeong Hong, Pinpin Sui, Ying Li, et al.
Nature Medicine|December 4, 2019
A selective BCL-X<sub>L</sub> PROTAC degrader achieves safe and potent antitumor activitySajid Khan, Xuan Zhang, Dongwen Lv, et al.
Cancer Research|December 2, 2025
Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Anti-tumor ImmunityDeepika Singh, Benjamin C Onyeagucha, Daisy Medina, et al.
Molecular Cell|October 5, 2023
Crucial roles of the BRCA1-BARD1 E3 ubiquitin ligase activity in homology-directed DNA repairMeiling Wang, Wenjing Li, Nozomi Tomimatsu, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Nature Communications|November 26, 2021
Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activityDongwen Lv, Pratik Pal, Xingui Liu, et al.
EMBO Molecular Medicine|February 19, 2025
Targeting cIAP2 in a novel senolytic strategy prevents glioblastoma recurrence after radiotherapyNozomi Tomimatsu, Luis Fernando Macedo Di Cristofaro, Suman Kanji, et al.
Nature Communications|January 26, 2023
DNA binding and RAD51 engagement by the BRCA2 C-terminus orchestrate DNA repair and replication fork preservationYoungho Kwon, Heike Rösner, Weixing Zhao, et al.
Cancer Research|March 5, 2022
Tumor Intrinsic PD-L1 Promotes DNA Repair in Distinct Cancers and Suppresses PARP Inhibitor-Induced Synthetic LethalityAnand V R Kornepati, Jacob T Boyd, Clare E Murray, et al.
Communications Biology|May 24, 2022
Targeting aberrant replication and DNA repair events for treating breast cancersSubapriya Rajamanickam, Jun Hyoung Park, Panneerdoss Subbarayalu, et al.
European Urology Oncology|November 15, 2024
Colibactin Exerts Androgen-dependent and -independent Effects on Prostate CancerRaag Agrawal, Sarah Al-Hiyari, Rupert Hugh-White, et al.
Cell Stem Cell|February 15, 2025
PSPC1 exerts an oncogenic role in AML by regulating a leukemic transcription program in cooperation with PU.1Juyeong Hong, Pinpin Sui, Ying Li, et al.
Nature Medicine|December 4, 2019
A selective BCL-X<sub>L</sub> PROTAC degrader achieves safe and potent antitumor activitySajid Khan, Xuan Zhang, Dongwen Lv, et al.
Cancer Research|December 2, 2025
Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Anti-tumor ImmunityDeepika Singh, Benjamin C Onyeagucha, Daisy Medina, et al.
Molecular Cell|October 5, 2023
Crucial roles of the BRCA1-BARD1 E3 ubiquitin ligase activity in homology-directed DNA repairMeiling Wang, Wenjing Li, Nozomi Tomimatsu, et al.
Pageof 11